z-logo
open-access-imgOpen Access
Recombinant Protein D from Haemophilus influenzae Induces Mouse Bactericidal Antibodies Against Typeable and Non-Typeable Haemophilus influenzae, which Partially Protect Infant Rats Against Serotype b Bacteraemia
Author(s) -
Nathan Palmer,
Yajun Tan,
Manolya Saydam,
Arif Felek,
Huajie Zhang,
Shumin Zhang,
Min Fang,
Jun X. Wheeler,
Qing Hou,
Ma Xiao,
Junzhi Wang,
Fatme Mawas
Publication year - 2020
Publication title -
vaccination research
Language(s) - English
Resource type - Journals
ISSN - 2771-750X
DOI - 10.17140/vroj-5-116
Subject(s) - haemophilus influenzae , immunogenicity , microbiology and biotechnology , antibody , recombinant dna , biology , serotype , virology , in vivo , immune system , immunoglobulin g , pasteurellaceae , immunology , antibiotics , gene , biochemistry
Aim To evaluate the immunogenicity of a recombinant protein D from Haemophilus Influenzae (Hi) and the functional activities of the induced protein D antibodies in a mouse model. Methods Female Balb/c mice were immunised subcutaneously with recombinant protein D in the presence or absence of adjuvants and the serum immunoglobulin G (IgG) response to protein D was assessed by ELISA. The functional activity of the immune sera was evaluated in vitro using bactericidal assay against typeable Hi serotype b (Hib) and non-typeable Hi (NTHi) clinical isolates and in vivo using an infant rat bacteraemia model and a Hib clinical isolate. Results A dose-dependent IgG response was induced in mice immunised with the recombinant protein D and this response was further increased by the adjuvants used [CPG, AlPO4 and Al(OH)3], with the latter showing the greatest effect on the antibody response. Immune sera were very effective in bactericidal assay against several Hib and NTHi clinical isolates, with a higher serum bactericidal titre against the NTHi than against the Hib isolates. This is possibly due to the lower expression of protein D on the Hib isolates used in our study, compared to the NTHi isolates. In addition, anti-protein D antibodies were partially protective in vivo infant rat bacteraemia model against a challenge with Hib Eagan strain. Conclusion Our results suggest that recombinant protein D is a good vaccine candidate against Hi and should be given in combination with other vaccine candidates to ensure complete protection against Hib and NTHi.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here